A Basque biotech company has developed several efficacy “in vivo” assays through zebrafish animal model. The potential efficacy of compounds in different therapeutic areas can be determined. These assays allow to predict potential effects of compounds in the “in vivo” zebrafish animal model at early stages of the Drug Discovery process. Looking for companies interested in outsourcing of already developed assays and/or taylor made efficacy assays of potential drugs.

For further information, please contact:
Enrique Machuca
Bio-Health Sector Responsible